Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study
International Journal of COPD2017Vol. Volume 12, pp. 745–755
Citations Over TimeTop 10% of 2017 papers
Edward Kerwin, Chris Kalberg, Dmitry Galkin, Chang‐Qing Zhu, Alison Church, John Riley, William A. Fahy
Abstract
UMEC/VI step-up therapy provides clinical benefit over TIO monotherapy in patients with moderate COPD who are symptomatic on TIO alone.
Related Papers
- → Using Post-bronchodilator FEV1 is Better Than Pre-bronchodilator FEV1 in Evaluation of COPD Severity(2012)28 cited
- → Bronchodilator therapy for bronchiolitis(2005)5 cited
- → (2006)1 cited
- Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy(2006)
- Increasing awareness of recognition of chronic obstructive pulmonary disease(2006)